Literature DB >> 27848883

Osteopontin as a Potential Therapeutic Target for Ischemic Stroke.

Qiquan Zhu1, Xu Luo1, Jie Zhang1, Yun Liu1, Hansheng Luo1, Qin Huang1, Yuan Cheng1, Zongyi Xie1.   

Abstract

BACKGROUND: Ischemic stroke is the third leading cause of death and the most frequent cause of permanent disability in adults worldwide. Tremendous advances have been made in understanding of the pathophysiology of cerebral ischemia. Nevertheless, there is still no effective neuroprotectant available in the clinical work. Recently, osteopontin (OPN), a glycophosphoprotein, has attracted more attention due to its various effects in cardiovascular and nervous system diseases.
OBJECTIVE: The aim of present review was to summarize recent findings about neuroprotective effects of OPN on ischemic stroke, targeting to provide a novel therapeutic strategy.
METHODS: To prepare this review, a pathophysiological and pharmacological literature survey was performed using PubMed, and Web of Science. Also, some statistical and epidemiological literature sources were used.
RESULTS: Mounting evidence indicates that OPN attenuates cerebral damage and promotes neurogenesis in ischemic stroke by binding to its receptors to activate diverse signaling pathways.
CONCLUSION: The paper highlights the neuroprotective and pro-regenerative effects of OPN after cerebral ischemia, which would demonstrate its therapeutic potential in ischemic stroke and other informs of ischemic brain injury. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Apoptosis; blood-brain barrier breakdown; neuroinflammation; neuroprotection; osteopontin; stroke

Mesh:

Substances:

Year:  2017        PMID: 27848883     DOI: 10.2174/1567201814666161116162148

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  8 in total

1.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

2.  Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke.

Authors:  Kai Zheng; Lingmin Lin; Wei Jiang; Lin Chen; Xiyue Zhang; Qian Zhang; Yi Ren; Junwei Hao
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-09       Impact factor: 6.960

3.  Apoptotic and antimetastatic activities of betulin isolated from Quercus incana against non-small cell lung cancer cells.

Authors:  Binte Zehra; Ayaz Ahmed; Rizwana Sarwar; Ajmal Khan; Umar Farooq; Syed Abid Ali; Ahmed Al-Harrasi
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

4.  Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.

Authors:  Grace Sanghee Lee; Hector F Salazar; Giji Joseph; Zoe Shin Yee Lok; Courtney M Caroti; Daiana Weiss; W Robert Taylor; Alicia N Lyle
Journal:  Lab Invest       Date:  2018-06-29       Impact factor: 5.662

5.  Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke.

Authors:  Daniel Spitzer; Sylvaine Guérit; Tim Puetz; Maryam I Khel; Moritz Armbrust; Maika Dunst; Jadranka Macas; Jenny Zinke; Gayatri Devraj; Xiaoxiong Jia; Florian Croll; Kathleen Sommer; Katharina Filipski; Thomas M Freiman; Mario Looso; Stefan Günther; Mariangela Di Tacchio; Karl-Heinz Plate; Yvonne Reiss; Stefan Liebner; Patrick N Harter; Kavi Devraj
Journal:  Acta Neuropathol       Date:  2022-06-25       Impact factor: 15.887

6.  Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness.

Authors:  Amra Jujić; Peter M Nilsson; Naeimeh Atabaki-Pasdar; Anna Dieden; Tiinamaija Tuomi; Paul W Franks; Jens Juul Holst; Signe Sørensen Torekov; Susana Ravassa; Javier Díez; Margaretha Persson; Emma Ahlqvist; Olle Melander; Maria F Gomez; Leif Groop; Martin Magnusson
Journal:  Diabetes Care       Date:  2020-11-18       Impact factor: 19.112

Review 7.  Monocyte Transmodulation: The Next Novel Therapeutic Approach in Overcoming Ischemic Stroke?

Authors:  Joohyun Park; Ji Young Chang; Jong Youl Kim; Jong Eun Lee
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

Review 8.  Osteopontin as a candidate of therapeutic application for the acute brain injury.

Authors:  Yunxiang Zhou; Yihan Yao; Lesang Sheng; Jianmin Zhang; John H Zhang; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-07-13       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.